Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal



Hazard - P - B - T - Risk See below

Risk. See below.

Assessment report

Assessment report for Ajovy (fremanezumab) 31 January 2019 EMA/118499/2019.

"Ecotoxicity/environmental risk assessment of fremanezumab was not conducted. As a monoclonal antibody, fremanezumab is not expected to pose a risk to the environment as it is metabolised to aminoacids."

Fass environmental information

Environmental information for fremanezumab is not available on Fass.se (2020-10-06). It is voluntary for manufacturers to publish environmental impact information on Fass.se.

Author: Health and Medical Care Administration, Region Stockholm